Coronary calcium screening has evolved from expensive research tool to mainstream risk assessment, but fixation on Agatston scores obscures sophisticated plaque analysis. Zero calcium cannot exclude disease in younger patients, while elevated scores demand intensive prevention regardless of traditional risk calculations.